Capricor Therapeutics
CAPR
#5196
Rank
โ‚น159.19 B
Marketcap
โ‚น2,749
Share price
-2.40%
Change (1 day)
207.88%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -โ‚น9.2 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -โ‚น3.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น10.01 Billion159.57%
2024 -โ‚น3.86 Billion81.57%
2023 -โ‚น2.13 Billion-23.2%
2022 -โ‚น2.77 Billion44.93%
2021 -โ‚น1.91 Billion46.61%
2020 -โ‚น1.31 Billion78.71%
2019 -โ‚น0.73 Billion-49.7%
2018 -โ‚น1.45 Billion-724.78%
2017 โ‚น0.23 B-112.93%
2016 -โ‚น1.8 Billion46.27%
2015 -โ‚น1.23 Billion106.82%
2014 -โ‚น0.6 Billion-48.41%
2013 -โ‚น1.15 Billion977.23%
2012 -โ‚น0.11 Billion-77.11%
2011 -โ‚น0.47 Billion-22.35%
2010 -โ‚น0.6 Billion-20.17%
2009 -โ‚น0.76 Billion-41.17%
2008 -โ‚น1.28 Billion41.05%
2007 -โ‚น0.91 Billion1098.87%
2006 -โ‚น75.46 Million4101.55%
2005 -โ‚น1.8 Million-0.97%
2004 -โ‚น1.82 Million17.87%
2003 -โ‚น1.54 Million3.66%
2002 -โ‚น1.49 Million-30.11%
2001 -โ‚น2.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.473 T-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น76.06 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น79 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.37 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.46 Billion-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.91 Billion-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA